Literature DB >> 18000365

Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.

C A Griffin1, L Morsberger, A L Hawkins, M Haddadin, A Patel, T Ried, E Schrock, E J Perlman, E Jaffee.   

Abstract

Karyotype analysis can provide clues to significant genes involved in the genesis and growth of pancreas cancer. The genome of pancreas cancer is complex, and G-band analysis cannot resolve many of the karyotypic abnormalities seen. We studied the karyotypes of 15 recently established cell lines using molecular cytogenetic tools. Comparative genomic hybridization (CGH) analysis of all 15 lines identified genomic gains of 3q, 8q, 11q, 17q, and chromosome 20 in nine or more cell lines. CGH confirmed frequent loss of chromosome 18, 17p, 6q, and 8p. 14/15 cell lines demonstrated loss of chromosome 18q, either by loss of a copy of chromosome 18 (n = 5), all of 18q (n = 7) or portions of 18q (n = 2). Multicolor FISH (Spectral Karyotyping, or SKY) of 11 lines identified many complex structural chromosomal aberrations. 93 structurally abnormal chromosomes were evaluated, for which SKY added new information to 67. Several potentially site-specific recurrent rearrangements were observed. Chromosome region 18q11.2 was recurrently involved in nine cell lines, including formation of derivative chromosomes 18 from a t(18;22) (three cell lines), t(17;18) (two cell lines), and t(12;18), t(15;18), t(18;20), and ins(6;18) (one cell line each). To further define the breakpoints involved on chromosome 18, YACs from the 18q11.2 region, spanning approximately 8 Mb, were used to perform targeted FISH analyses of these lines. We found significant heterogeneity in the breakpoints despite their G-band similarity, including multiple independent regions of loss proximal to the already identified loss of DPC4 at 18q21. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18000365     DOI: 10.1159/000108295

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  19 in total

1.  Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.

Authors:  Ming-Tseh Lin; Li-Hui Tseng; Hirohiko Kamiyama; Mihoko Kamiyama; Phillip Lim; Manuel Hidalgo; Sarah Wheelan; James Eshleman
Journal:  Biotechniques       Date:  2010-03       Impact factor: 1.993

2.  Transflip mutations produce deletions in pancreatic cancer.

Authors:  Alexis L Norris; Hirohiko Kamiyama; Alvin Makohon-Moore; Aparna Pallavajjala; Laura A Morsberger; Kurt Lee; Denise Batista; Christine A Iacobuzio-Donahue; Ming-Tseh Lin; Alison P Klein; Ralph H Hruban; Sarah J Wheelan; James R Eshleman
Journal:  Genes Chromosomes Cancer       Date:  2015-05-29       Impact factor: 5.006

3.  Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.

Authors:  Xin Zheng; Lei Gao; Bo-Tao Wang; Ping Shen; Xiang-Fei Yuan; Lan-Qiu Zhang; Lei Yang; Da-Peng Zhang; Qi Zhang; Xi-Mo Wang
Journal:  Histol Histopathol       Date:  2019-11-20       Impact factor: 2.303

4.  Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.

Authors:  Tatsuo Hata; Marco Dal Molin; Anne McGregor-Das; Tae Jun Song; Christopher Wolfgang; James R Eshleman; Ralph H Hruban; Michael Goggins
Journal:  J Mol Diagn       Date:  2017-12-08       Impact factor: 5.568

Review 5.  Chromosomal instability and aneuploidy in cancer: from yeast to man.

Authors:  Sarah J Pfau; Angelika Amon
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

6.  Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.

Authors:  Jaclyn Andricovich; Stephanie Perkail; Yan Kai; Nicole Casasanta; Weiqun Peng; Alexandros Tzatsos
Journal:  Cancer Cell       Date:  2018-03-12       Impact factor: 31.743

7.  Familial and sporadic pancreatic cancer share the same molecular pathogenesis.

Authors:  Alexis L Norris; Nicholas J Roberts; Siân Jones; Sarah J Wheelan; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Alison P Klein; James R Eshleman
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

8.  Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.

Authors:  Arkadeep Sinha; David Cherba; Heather Bartlam; Elizabeth Lenkiewicz; Lisa Evers; Michael T Barrett; Brian B Haab
Journal:  Mol Oncol       Date:  2014-05-02       Impact factor: 6.603

9.  Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.

Authors:  Gordon W Dewald; Thomas C Smyrk; Erik C Thorland; Robert R McWilliams; Daniel L Van Dyke; Jeannette G Keefe; Kimberly J Belongie; Stephanie A Smoley; Darlene L Knutson; Stephanie R Fink; Anne E Wiktor; Gloria M Petersen
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

10.  Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.

Authors:  Felix H Shek; Sarwat Fatima; Nikki P Lee
Journal:  Int J Hepatol       Date:  2012-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.